Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.
Zhou P, Chen J, He J, Zheng T, Yunis J, Makota V, Alexandre YO, Gong F, Zhang X, Xie W, Li Y, Shao M, Zhu Y, Sinclair JE, Miao M, Chen Y, Short KR, Mueller SN, Sun X, Yu D, Li Z.
Zhou P, et al. Among authors: xie w.
PLoS Pathog. 2021 Oct 7;17(10):e1009858. doi: 10.1371/journal.ppat.1009858. eCollection 2021 Oct.
PLoS Pathog. 2021.
PMID: 34618873
Free PMC article.